100 filings
Page 3 of 5
8-K
7mywd0150kpie4j siox
8 Feb 22
Departure of Directors or Certain Officers
4:23pm
8-K
jk47xh784c0gi5ws
4 Jan 22
Other Events
8:08am
8-K
kgcc2tc4 c2n5u
3 Jan 22
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy
8:08am
8-K
bie65 aet186xq8b
17 Nov 21
Other Events
7:30am
8-K
lkiape7qgi
15 Oct 21
Departure of Directors or Certain Officers
4:36pm
8-K
0jcp2o v34
29 Sep 21
Departure of Directors or Certain Officers
4:17pm
8-K
la62b b9kno0l
28 Sep 21
Departure of Directors or Certain Officers
4:17pm
8-K
wvqig p3zo0
12 Jul 21
Other Events
8:14am
8-K
kim294g
28 Jun 21
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy
4:22pm
8-K
44syzl9
13 May 21
Other Events
4:58pm
8-K
1pp5c6 cd0v7auh20
25 Mar 21
Departure of Directors or Certain Officers
4:24pm
8-K
7alau7bv gil
9 Mar 21
Entry into a Material Definitive Agreement
9:06am
8-K
wjuvk rl8a4b
2 Mar 21
Other Events
4:44pm
8-K
64bw6
9 Feb 21
Genprex, Inc. Announces $25 Million
4:59pm
8-K
patoplk7g9le
28 Jan 21
Other Events
4:30pm
8-K
dlcu4u1s 0d
23 Dec 20
Genprex, Inc. Announces $12 Million
4:41pm
8-K
z4wdt
16 Nov 20
Other Events
4:33pm
8-K
emddk
29 Sep 20
Other Events
9:06am
8-K
pgyk4y 778iqvv39
27 Aug 20
Departure of Directors or Certain Officers
4:21pm
8-K
dwdx8n6y6des k6eh
14 Aug 20
Departure of Directors or Certain Officers
8:39am